Interestingly, miR-340 overexpression was also able to decrease NRAS protein levels in three different breast cancer cell lines (BT-549, MDA-MB-231, MCF7; Figure 2E) and two NSCLC cell lines (A549, Calu-1; Figure 2F). This evidence concerns the gene NRAS and breast carcinoma.